(2S)-2-[(3S,8S,9S,10R,13S,14S,16R,17R)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-16-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-7-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one

Details

Top
Internal ID c115dfbc-c78f-4a0e-86ef-a0f1cf41dff3
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides
IUPAC Name (2S)-2-[(3S,8S,9S,10R,13S,14S,16R,17R)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-16-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-7-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one
SMILES (Canonical) CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3CCC4(C5CCC6(C(C5CC=C4C3)CC(C6C(C)C(=O)CCC(C)COC7C(C(C(C(O7)CO)O)O)O)O)C)C)CO)O)O)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O[C@H]3CC[C@@]4([C@H]5CC[C@]6([C@H]([C@@H]5CC=C4C3)C[C@H]([C@@H]6[C@H](C)C(=O)CCC(C)CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)C)C)CO)O)O)O
InChI InChI=1S/C45H74O18/c1-19(18-58-41-37(55)35(53)33(51)29(16-46)61-41)6-9-27(48)20(2)31-28(49)15-26-24-8-7-22-14-23(10-12-44(22,4)25(24)11-13-45(26,31)5)60-43-39(57)36(54)40(30(17-47)62-43)63-42-38(56)34(52)32(50)21(3)59-42/h7,19-21,23-26,28-43,46-47,49-57H,6,8-18H2,1-5H3/t19?,20-,21+,23+,24-,25+,26+,28-,29-,30-,31+,32+,33-,34-,35+,36-,37-,38-,39-,40-,41-,42+,43-,44+,45+/m1/s1
InChI Key ILXXMYNIRCQYPP-DAISYDLXSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C45H74O18
Molecular Weight 903.10 g/mol
Exact Mass 902.48751551 g/mol
Topological Polar Surface Area (TPSA) 295.00 Ų
XlogP -0.80
Atomic LogP (AlogP) -0.99
H-Bond Acceptor 18
H-Bond Donor 11
Rotatable Bonds 14

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2S)-2-[(3S,8S,9S,10R,13S,14S,16R,17R)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-16-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-7-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyheptan-3-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7838 78.38%
Caco-2 - 0.8854 88.54%
Blood Brain Barrier - 0.6250 62.50%
Human oral bioavailability - 0.8143 81.43%
Subcellular localzation Mitochondria 0.8076 80.76%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8561 85.61%
OATP1B3 inhibitior - 0.2313 23.13%
MATE1 inhibitior - 0.9812 98.12%
OCT2 inhibitior - 0.6776 67.76%
BSEP inhibitior + 0.7110 71.10%
P-glycoprotein inhibitior + 0.7391 73.91%
P-glycoprotein substrate + 0.6457 64.57%
CYP3A4 substrate + 0.7513 75.13%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8581 85.81%
CYP3A4 inhibition - 0.9495 94.95%
CYP2C9 inhibition - 0.9335 93.35%
CYP2C19 inhibition - 0.9392 93.92%
CYP2D6 inhibition - 0.9467 94.67%
CYP1A2 inhibition - 0.9243 92.43%
CYP2C8 inhibition + 0.6713 67.13%
CYP inhibitory promiscuity - 0.9590 95.90%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6109 61.09%
Eye corrosion - 0.9909 99.09%
Eye irritation - 0.9105 91.05%
Skin irritation + 0.5259 52.59%
Skin corrosion - 0.9457 94.57%
Ames mutagenesis - 0.9178 91.78%
Human Ether-a-go-go-Related Gene inhibition + 0.7754 77.54%
Micronuclear - 0.8600 86.00%
Hepatotoxicity - 0.8375 83.75%
skin sensitisation - 0.9254 92.54%
Respiratory toxicity + 0.7222 72.22%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.5250 52.50%
Nephrotoxicity - 0.9429 94.29%
Acute Oral Toxicity (c) III 0.4565 45.65%
Estrogen receptor binding + 0.8600 86.00%
Androgen receptor binding + 0.7441 74.41%
Thyroid receptor binding - 0.5226 52.26%
Glucocorticoid receptor binding + 0.7148 71.48%
Aromatase binding + 0.6890 68.90%
PPAR gamma + 0.7760 77.60%
Honey bee toxicity - 0.6463 64.63%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5955 59.55%
Fish aquatic toxicity + 0.9296 92.96%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 99.17% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.27% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 95.63% 95.93%
CHEMBL2581 P07339 Cathepsin D 95.02% 98.95%
CHEMBL253 P34972 Cannabinoid CB2 receptor 94.80% 97.25%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.32% 97.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 92.34% 89.00%
CHEMBL1994 P08235 Mineralocorticoid receptor 91.66% 100.00%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 90.27% 95.89%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 90.07% 89.05%
CHEMBL3359 P21462 Formyl peptide receptor 1 89.44% 93.56%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.27% 94.45%
CHEMBL5255 O00206 Toll-like receptor 4 86.22% 92.50%
CHEMBL4227 P25090 Lipoxin A4 receptor 85.54% 100.00%
CHEMBL2140 P48775 Tryptophan 2,3-dioxygenase 83.80% 98.46%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 83.38% 96.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.14% 95.89%
CHEMBL5028 O14672 ADAM10 82.82% 97.50%
CHEMBL237 P41145 Kappa opioid receptor 82.59% 98.10%
CHEMBL1293249 Q13887 Kruppel-like factor 5 80.77% 86.33%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 80.65% 95.56%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Solanum abutiloides

Cross-Links

Top
PubChem 10819557
LOTUS LTS0152920
wikiData Q105115542